Limbic has been selected for the US Food and Drug [...]

AC Immune has received FDA Fast Track designation and IND [...]

The FDA has issued a Complete Response Letter for ITM-11, [...]

Adneuris Therapeutics has granted Maruishi Pharmaceutical exclusive rights to develop [...]

BlueWind Medical has received FDA 510(k) clearance for Revi Extend, [...]

Obsidian Therapeutics has enrolled the first patient in the registration-enabling [...]

The US Food and Drug Administration (FDA) has approved Meitheal [...]

PolyPid’s D-PLEX100 has been granted FDA Priority Review following acceptance [...]

HAYA Therapeutics has received FDA Fast Track designation for HTX-001, [...]

Medicus Pharma has received FDA clearance to begin a Phase [...]